Lyra Therapeutics, Inc. (LYRA) Free cash flow 2019–2025
Lyra Therapeutics, Inc. (LYRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.0MFY2025 · since FY2019: -$14.0M → -$29.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.0M | +60.0% |
| FY2024 | -$72.3M | -12.4% |
| FY2023 | -$64.4M | -47.8% |
| FY2022 | -$43.5M | -49.1% |
| FY2021 | -$29.2M | -27.4% |
| FY2020 | -$22.9M | -64.1% |
| FY2019 | -$14.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice